logo

CHRS Stock on the Rise: A Promising Investment

ZM Stock

In terms of market performance, Coherus Biosciences Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $5.47 on 09/01/23, while the lowest value was $1.22 on 08/07/24.

52-week price history of CHRS Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Coherus Biosciences Inc’s current trading price is -76.94% away from its 52-week high, while its distance from the 52-week low is 3.28%. The stock’s price range for this period has remained between $1.22 and $5.47. The Healthcare sector company’s shares managed to surpass a trading volume of around 5.77 million for the day, which was noticeably higher compared to the shares’ average daily volume of 1.63 million over the last three months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Financial Performance and Market Capitalization

Coherus Biosciences Inc (CHRS) has experienced a quarterly decline of -41.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 145.16M and boasts a workforce of 306 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.8479, with a change in price of -1.0200. Similarly, Coherus Biosciences Inc recorded 1,772,770 in trading volume during the last 100 days, posting a change of -44.74%.

CHRS Stock Stochastic Average

As of today, the raw stochastic average of Coherus Biosciences Inc over the past 50 days is 5.84%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 7.69%. Additionally, the Stochastic %K and %D values for the company were 33.33% and 35.60%, respectively, over the past 20 days.

CHRS Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded a decrease of -62.16%. However, over the last six months, the performance has been stronger by -55.79%. The price of CHRS decreased -19.75% over the last 30 days. And in the last five days, it has fallen by -11.89%.

Most Popular